Press release
Deadline on June 25th coming up in Lawsuit for Investors in Exscientia plc (NASDAQ: EXAI)
A Deadline is coming up on June 25, 2024 in the lawsuit for certain investors in Exscientia plc (NASDAQ: EXAI).
Investors who purchased shares of Exscientia plc (NASDAQ: EXAI) have certain options and there are strict and short deadlines running. Deadline: June 25, 2024. NASDAQ: EXAI stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
According to the complaint filed in the U.S. District Court for the District of New Jersey the plaintiff alleges on behalf of purchasers of Exscientia plc (NASDAQ: EXAI) common shares between March 23, 2022, and February 12, 2024, that the defendants violated Federal Securities Laws. More specifically, the plaintiff claims that between March 23, 2022, and February 12, 2024, the Defendants made false and/or misleading statements and/or failed to disclose that Defendant Hopkins had engaged in improper relationships with employees that were inconsistent with the Company's standards and values, that Defendant Nicholson had prior knowledge of Defendant Hopkins's relationships and had improperly addressed Hopkins's misconduct without consulting the Board, that the Company's maintenance and enforcement of its Code of Business Conduct and Ethics was inadequate to safeguard against the foregoing conduct, that the foregoing failures subjected the Company to a heightened risk of disruptive leadership transitions and/or reputational harm, and that as a result, Defendants' public statements were materially false and/or misleading at all relevant times.
Those who purchased shares of Exscientia plc (NASDAQ: EXAI) have certain options and should contact the Shareholders Foundation.
Contact:
Michael Daniels
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
E-Mail: mail@shareholdersfoundation.com
About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities lawsuits, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Deadline on June 25th coming up in Lawsuit for Investors in Exscientia plc (NASDAQ: EXAI) here
News-ID: 3540041 • Views: …
More Releases from Shareholders Foundation, Inc.
NASDAQ: REPL Investor Alert: Lawsuit against Replimune Group, Inc. seeks to reco …
An investor, who purchased shares of Replimune Group, Inc. (NASDAQ: REPL), filed a lawsuit over alleged violations of Federal Securities Laws by Replimune Group, Inc in connection with certain allegedly false and misleading statements.
Investors who purchased shares of Replimune Group, Inc. (NASDAQ: REPL) have certain options and for certain investors are short and strict deadlines running. Deadline: October 5, 2026. NASDAQ: REPL investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com…
NYSE: BMI Long Term Investor Alert: Investigation over potential Wrongdoing by c …
An investigation was announced for long-term investors in shares of Badger Meter, Inc. (NYSE: BMI) concerning potential breaches of fiduciary duties by certain directors of Badger Meter, Inc. was announced.
Investors who are current long term investors in Badger Meter, Inc. (NYSE: BMI) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm for current long term…
Lawsuit Alert: Investors who lost money with ARS Pharmaceuticals, Inc. (NASDAQ: …
An investor, who purchased shares of ARS Pharmaceuticals, Inc. (NASDAQ: SPRY), filed a lawsuit over alleged violations of Federal Securities Laws by ARS Pharmaceuticals, Inc. in connection with certain allegedly false and misleading statements.
Investors who purchased shares of ARS Pharmaceuticals, Inc. (NASDAQ: SPRY) have certain options and for certain investors are short and strict deadlines running. Deadline: October 5, 2026. NASDAQ: SPRY investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com…
Investigation Alert: Investors in GeneDx Holdings Corp. (NASDAQ: WGS) should con …
An investigation was announced for current long-term investors in shares of GeneDx Holdings Corp. (NASDAQ: WGS) concerning potential breaches of fiduciary duties by certain directors and officers of GeneDx Holdings Corp.
Investors who are current long term investors in GeneDx Holdings Corp. (NASDAQ: WGS) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm for current long term…
More Releases for Exscientia
AI for Drug Discovery Market Analysis By Key Players IBM Watson ,Exscientia,etc
The AI for drug discovery refers to the application of machine learning, deep learning, predictive analytics, natural language processing, and other advanced computational technologies to identify and develop new therapeutic compounds.
Get Sample Report@ https://www.theinsightpartners.com/sample/TIPRE00004177?utm_source=OpenPR&utm_medium=10921
For instant assistance or inquiries, please contact us at: sales@theinsightpartners.com
According to The Insight Partners, The global AI for Drug Discovery market is projected to reach approximately US$11.71 billion by 2031, growing at a compound annual growth rate…
Artificial Intelligence in Life Science Market Is Booming So Rapidly |Insilico M …
The Global Artificial Intelligence in Life Science Market is estimated to be valued at USD 4.68 Bn in 2026 and is expected to reach USD 22.95 Bn by 2033, exhibiting a compound annual growth rate (CAGR) of 25.5% from 2026 to 2033.
The latest research study published by Coherent Market Insights on the "Artificial Intelligence in Life Science Market Forecast 2026-2033" delivers precise economic insights along with global and country-level forecasts…
AI Drug Discovery Market Is Going to Boom | Major Giants Insilico Medicine, Bene …
The latest study released on the Global AI Drug Discovery Market by HTF MI Research evaluates market size, trend, and forecast to 2033. The AI Drug Discovery study covers significant research data and proofs to be a handy resource document for managers, analysts, industry experts and other key people to have ready-to-access and self-analyzed study to help understand market trends, growth drivers, opportunities and upcoming challenges and about the competitors.
Consider…
AI in Biotech Market Is Going to Boom| Major Giants Schrödinger, Healx, Valo H …
HTF MI just released the Global AI in Biotech Market Study, a comprehensive analysis of the market that spans more than 143+ pages and describes the product and industry scope as well as the market prognosis and status for 2025-2033. The marketization process is being accelerated by the market study's segmentation by important regions. The market is currently expanding its reach.
Key Manufacturers and Players in This Report:
IBM Watson Health, BenevolentAI,…
AI in Pharmaceutical Market May Set New Growth Story | IBM Watson Health, Benevo …
HTF MI just released the Global AI in Pharmaceutical Market Study, a comprehensive analysis of the market that spans more than 143+ pages and describes the product and industry scope as well as the market prognosis and status for 2025-2032. The marketization process is being accelerated by the market study's segmentation by important regions. The market is currently expanding its reach.
Major Giants in AI in Pharmaceutical Market are:
IBM Watson Health,…
Investigation announced for Investors in Exscientia plc (NASDAQ: EXAI) over poss …
Exscientia plc is under investigation over potential securities laws violations in connection with certain financial statements.
Investors who purchased shares of Exscientia plc (NASDAQ: EXAI), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm focuses on possible claims on behalf of purchasers of the securities of Exscientia plc (NASDAQ: EXAI) concerning whether a series of statements by Exscientia…
